Acorn Capital Advisors, Llc Stock Trading & 13F Insights
13F Portfolio Filings
- Most recent 13FQ4 2025
- Locationnew york, NY
- CIK0002054410
- All SEC filings
Q4 2025 Summary
Quarter | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
21 | $295.13M | TERN, CGON, UROGEN PHARMA LTD, TREVI THERAPEUTICS INC | 13F-HR | Feb 17, 2026 | 000163658726000005 | ||
20 | $196.99M | CGON, UROGEN PHARMA LTD, PBYI, TREVI THERAPEUTICS INC | 13F-HR | Nov 17, 2025 | 000163658725000060 | ||
21 | $152.89M | CGON, UROGEN PHARMA LTD, YMAB, PBYI | 13F-HR | Aug 14, 2025 | 000163658725000043 | ||
22 | $149.95M | CGON, UROGEN PHARMA LTD, YMAB, TREVI THERAPEUTICS INC | RESTATEMENT | May 19, 2025 | 000163658725000021 | ||
21 | $185.82M | CGON, YMAB, CADL, UROGEN PHARMA LTD | RESTATEMENT | May 19, 2025 | 000163658725000020 | ||
21 | $190.48M | CGON, YMAB, CADL, UROGEN PHARMA LTD | NEW HOLDINGS | May 7, 2025 | 000163658725000016 |